Inflammatory bowel disease (IBD) is a risk factor for extrahepatic cholangiocarcinoma (ECC) in subjects without underlying primary sclerosing cholangitis (PSC)

被引:0
|
作者
Ghoz, Hassan M. [1 ,2 ]
Baichoo, Esha [1 ,2 ]
Addissie, Benyam D. [1 ,2 ]
Roberts, Lewis R. [1 ,2 ]
Chaiteerakij, Roongruedee [1 ,2 ,3 ,4 ]
机构
[1] Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Rochester, MN USA
[2] Mayo Clin, Ctr Canc, Rochester, MN USA
[3] Chulalongkorn Univ, Fac Med, Dept Med, Bangkok 10330, Thailand
[4] King Chulalongkorn Mem Hosp, Thai Red Cross Soc, Bangkok, Thailand
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1357
引用
收藏
页码:852A / 852A
页数:1
相关论文
共 50 条
  • [41] CHARACTERISTICS OF INFLAMMATORY BOWEL-DISEASE (IBD) IN SCLEROSING CHOLANGITIS (SC)
    DIEHL, AM
    HERLONG, HF
    GASTROENTEROLOGY, 1983, 84 (05) : 1137 - 1137
  • [42] Cholangiocarcinoma in a 17-year-old Boy With Primary Sclerosing Cholangitis and Inflammatory Bowel Disease
    Deneau, Mark
    Adler, Douglas G.
    Schwartz, Jason J.
    Hutson, William
    Sorensen, John
    Book, Linda
    Lowichik, Amy
    Guthery, Stephen
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2011, 52 (05): : 617 - 620
  • [43] EFFICACY OF VEDOLIZUMAB IN REDUCING BILIARY INFLAMMATION IN PRIMARY SCLEROSING CHOLANGITIS (PSC) IN INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASE
    Tse, Chung Sang
    Loftus, Edward V.
    Raffals, Laura H.
    Gossard, Andrea
    Lightner, Amy L.
    GASTROENTEROLOGY, 2017, 152 (05) : S402 - S403
  • [44] Primary Sclerosing Cholangitis and Disease Distribution in Inflammatory Bowel Disease
    O'Toole, Aoibhlinn
    Alakkari, Alaa
    Keegan, Denise
    Doherty, Glen
    Mulcahy, Hugh
    O'Donoghue, Diarmuid
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2012, 10 (04) : 439 - 441
  • [45] Polygenic risk score predicts risk of primary sclerosing cholangitis in inflammatory bowel disease
    Wang, Ming-Hsi
    Friton, Jessica J.
    Raffals, Laura E.
    Leighton, Jonathan A.
    Pasha, Shabana F.
    Picco, Michael F.
    Monroe, Kelly
    Nix, Billy D.
    Newberry, Rodney D.
    Faubion, William A.
    BMJ OPEN GASTROENTEROLOGY, 2023, 10 (01):
  • [46] Are Dominant Strictures in Primary Sclerosing Cholangitis a Risk Factor for Cholangiocarcinoma?
    Roger W Chapman
    Kate D. Williamson
    Current Hepatology Reports, 2017, 16 (2) : 124 - 129
  • [47] Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis
    Harry Sokol
    Jacques Cosnes
    Olivier Chazouilleres
    Laurent Beaugerie
    Emmanuel Tiret
    Raoul Poupon
    Philippe Seksik
    World Journal of Gastroenterology, 2008, (22) : 3497 - 3503
  • [48] Risk of colorectal cancer in patients with primary sclerosing cholangitis and concomitant inflammatory bowel disease compared with primary sclerosing cholangitis only
    Das, Taranika Sarkar
    Ho, Kimberly
    Udaikumar, Jahnavi
    Chen, Bryan
    Delau, Olivia
    Shaukat, Aasma
    Jacobson, Ira
    Sarwar, Raiya
    HEPATOLOGY RESEARCH, 2024, 54 (09) : 807 - 816
  • [49] Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis
    Sokol, Harry
    Cosnes, Jacques
    Chazouilleres, Olivier
    Beaugerie, Laurent
    Tiret, Emmanuel
    Poupon, Raoul
    Seksik, Philippe
    WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (22) : 3497 - 3503
  • [50] Recurrent Bacterial Cholangitis as a Risk Factor of Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis
    Trilianos, Panagiotis
    Limketkai, Berkeley N.
    Gurakar, Ahmet
    HEPATOLOGY, 2012, 56 : 474A - 474A